Song Li

发表

Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes

B. Rosen, H. Risch, S. Narod, 2011, Journal of Medical Genetics.

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil

A. Monteiro, S. Narod, R. Borojevic, 2007, Breast Cancer Research and Treatment.

Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer

Zhankui Jia, Song Li, Xiang-Hui Ning, 2022, Frontiers in Immunology.

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Barry Rosen, B. Rosen, H. Risch, 2006, Journal of the National Cancer Institute.

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia

S. Narod, J. Weitzel, J. Madrid, 2014, Hereditary Cancer in Clinical Practice.

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

Stephanie A Cohen, C. Shapiro, S. Narod, 2009, BMC Cancer.

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

Barry Rosen, B. Rosen, H. Risch, 2011, Gynecologic oncology.

BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.

S. Vadaparampil, S. Narod, T. Pal, 2008, Genetic testing.

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

J. Lubiński, S. Narod, C. Cybulski, 2012, Breast Cancer Research and Treatment.

A low frequency of non‐founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families

S. Narod, C. Phelan, D. Hanna, 2002, Human mutation.

Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma

R. Malekzadeh, F. Islami, A. Pourshams, 2007, Oncogene.

BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.

S. Vadaparampil, S. Narod, T. Pal, 2008, Genetic testing.